Clinical Research and Trials in Stem Cells and Cancer


Clinical preliminaries are broadly observed for real advances in Cancer treatment because of developing new medications to avert or help oversee Graft-Versus-Host Disease (GvHD). Graft-Versus-Host Disease a typical and conceivably extreme reaction of stem cell transplants in which contributor safe cells attack solid patient cells and tissues. Creating cancer immunization systems for use alongside transplant to invigorate the Graft-Versus- leukaemia (GVL) impact and limit malady backslide. Graft-versus-Leukaemia has restorative impact in which transplanted invulnerable cells attack leftover leukaemia or other tumour cells.

    Related Conference of Clinical Research and Trials in Stem Cells and Cancer

    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France

    Clinical Research and Trials in Stem Cells and Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in